tetraethylammonium has been researched along with Leukemia in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BENKO, S | 1 |
| Schweinzer, E | 1 |
| Goldenberg, H | 1 |
2 other studies available for tetraethylammonium and Leukemia
| Article | Year |
|---|---|
[Hematological effect of tetraethylammonium-bromide; preliminary note].
Topics: Bromides; Leukemia; Tetraethylammonium | 1953 |
Monodehydroascorbate reductase activity in the surface membrane of leukemic cells. Characterization by a ferricyanide-driven redox cycle.
Topics: Animals; Ascorbic Acid; Cell Differentiation; Cell Membrane; Dehydroascorbic Acid; Ferricyanides; He | 1993 |